Literature DB >> 7362956

Peroperative antibiotics in the prevention of chest infection following cardiac operations.

R B Galland, D M Shama, K B Prenger, J H Darrell.   

Abstract

Seventy-nine patients about to undergo cardiac operations were randomly allocated to two treatment groups in an attempt to reduce postoperative chest infections. The group receiving a short peroperative course of cefamandole, an antibiotic effective against both the pneumococcus and Haemophilus influenzae, had a significantly lower postoperative chest infection rate than the group receiving a 3-day course of cephradine, an antibiotic previously chosen to prevent intracardiac infection during the operation. By selecting an appropriate antibiotic it is possible, using a short peroperative course, to reduce the postoperative chest infection rate in patients undergoing cardiac operations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362956     DOI: 10.1002/bjs.1800670208

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Perioperative antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative trial of cefazolin versus ceftriaxone.

Authors:  M Soteriou; F Recker; S Geroulanos; M Turina
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

2.  Bacterial and fungal infections after cardiac surgery in children.

Authors:  A Wessel; C Simon; D Regensburger
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

3.  Plasma and myocardial levels of cefonicid during open-heart surgery.

Authors:  R P Sterling; D J Connor; J C Norman
Journal:  J Natl Med Assoc       Date:  1983-11       Impact factor: 1.798

4.  Antibiotic prophylaxis in pulmonary surgery: a double-blind study of penicillin versus placebo.

Authors:  N Frimodt-Møller; P Ostri; I K Pedersen; S R Poulsen
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

Review 5.  Prophylaxis against sepsis in patients undergoing major surgery.

Authors:  W T Morris
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.